Policosanol for the Treatment of Hypercholesterolemia
NCT00255216
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Hyperlipidemia
Interventions
DRUG:
Policosanol supplement (oral capsule) vs. placebo
Sponsor
Wake Forest University Health Sciences